Grant: Discovery Grants Program - Individual
University of Ottawa
$25,000.00
Probing the Pharmacogenetic Underpinnings of Human Attention with Brain Potentials
EF 2013-14
Résumé
On a daily basis, we are faced with cluttered environments with sensory inputs that compete for our mental resources and, ultimately, for the control of behaviour. Coherent goal-directed behaviour relies on selection mechanisms in the brain to control the moment-to-moment flow of these inputs by allocating and stabilizing attention to task-relevant stimuli while enhancing the detection and processing of new and potentially goal-relevant stimuli. Acetylcholine is a neurotransmitter in the brain which is known to regulate 'selective attention', but exactly how it accomplishes this is unclear. Some animal and human research suggests that acetylcholine interacts with the neurotransmitter dopamine in different parts of the brain to facilitate attention to important stimuli and to suppress attention to unimportant stimuli. Individuals vary greatly in their ability to selectively attend and there is considerable evidence that these individual differences may have a genetic basis, with genes regulating dopamine possibly altering the way in which acetylcholine drugs affect attention. The objective of this research is to investigate individual differences in attentional response to an acetylcholine drug by comparing groups with different dopamine and acetylcholine genetic makeups, which determine the extent of dopamine and acetylcholine activity in the brain. In these studies, performance speed and accuracy will be measured along with brain electrical activity, which will help determine what specific aspects of attention are being altered. The acetylcholine drug will be CDP-choline, which is a metabolite of acetylcholine and has cognitive enhancing properties. This research will contribute to biological theories of human attention and its normal variation, which has relevance for human performance in work and everyday settings and may be useful in understanding disorders of attention.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
355737-2013
Name nom
Knott, Verner
Department département
Psychology, School of
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2013
Competition year année de concours
2013
Award amount
25000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1210
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Psychology
Area of application fr
Psychologie
Research subject code
6307
Research subject group en
Psychology
Research subject group fr
Psychologie
Research subject en
Cognitive science -- other
Research subject fr
Science cognitive -- autres
Partie
1
Nb partie
3
Application title
Probing the Pharmacogenetic Underpinnings of Human Attention with Brain Potentials
Keyword
NSERC
Application summary
On a daily basis, we are faced with cluttered environments with sensory inputs that compete for our mental resources and, ultimately, for the control of behaviour. Coherent goal-directed behaviour relies on selection mechanisms in the brain to control the moment-to-moment flow of these inputs by allocating and stabilizing attention to task-relevant stimuli while enhancing the detection and processing of new and potentially goal-relevant stimuli. Acetylcholine is a neurotransmitter in the brain which is known to regulate 'selective attention', but exactly how it accomplishes this is unclear. Some animal and human research suggests that acetylcholine interacts with the neurotransmitter dopamine in different parts of the brain to facilitate attention to important stimuli and to suppress attention to unimportant stimuli. Individuals vary greatly in their ability to selectively attend and there is considerable evidence that these individual differences may have a genetic basis, with genes regulating dopamine possibly altering the way in which acetylcholine drugs affect attention. The objective of this research is to investigate individual differences in attentional response to an acetylcholine drug by comparing groups with different dopamine and acetylcholine genetic makeups, which determine the extent of dopamine and acetylcholine activity in the brain. In these studies, performance speed and accuracy will be measured along with brain electrical activity, which will help determine what specific aspects of attention are being altered. The acetylcholine drug will be CDP-choline, which is a metabolite of acetylcholine and has cognitive enhancing properties. This research will contribute to biological theories of human attention and its normal variation, which has relevance for human performance in work and everyday settings and may be useful in understanding disorders of attention.